Symmetrical dimethylarginine predicts mortality in the general population: Observations from the dallas heart study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 11, 2013, Pages 2682-2688

  Gore, M Odette ^a   Lüneburg, Nicole ^c   Schwedhelm, Edzard ^c   Ayers, Colby R ^a,b   Anderssohn, Maike ^c   Khera, Amit ^a,b   Atzler, Dorothee ^c   De Lemos, James A ^a,b   Grant, Peter J ^d   McGuire, Darren K ^a,b   Böger, Rainer H ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

atherosclerosis; mortality; population; risk factors

Indexed keywords

6 N,N' DIMETHYLARGININE; CALCIUM; N(G),N(G) DIMETHYLARGININE; TROPONIN T;

ABDOMINAL AORTA; ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY; ELECTRON BEAM TOMOGRAPHY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; UNITED STATES;

ATHEROSCLEROSIS; MORTALITY; POPULATION; RISK FACTORS;

ADULT; AGED; ARGININE; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TEXAS;

EID: 84887113234     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.301219     Document Type: Article

References (16)

1. Schwedhelm E, Böger RH. The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol. 2011;7:275-285.
2. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol. 2006;147(suppl 1):S193-S201.
3. Blackwell S. The biochemistry, measurement and current clinical sig-nifcance of asymmetric dimethylarginine. Ann Clin Biochem. 2010;47(pt 1):17-28.
4. Maas R, Schulze F, Baumert J, Löwel H, Hamraz K, Schwedhelm E, Koenig W, Böger RH. Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data. Clin Chem. 2007;53:693-701.
5. Valkonen VP, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, Laakso J, Laaksonen R. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 2001;358:2127-2128.
6. Leong T, Zylberstein D, Graham I, Lissner L, Ward D, Fogarty J, Bengtsson C, Björkelund C, Thelle D; Swedish-Irish-Norwegian Collaboration. Asymmetric dimethylarginine independently predicts fatal and nonfa-tal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg. Arterioscler Thromb Vasc Biol. 2008;28:961-967.
7. Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, Schulze F, Xanthakis V, Benndorf RA, Vasan RS. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation. 2009;119:1592-1600.
8. Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, Atzler D, Grant PJ, Böger RH. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis. 2010;208:518-523.
9. Kiechl S, Lee T, Santer P, Thompson G, Tsimikas S, Egger G, Holt DW, Willeit J, Xu Q, Mayr M. Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis. 2009;205:261-265.
10. Krempl TK, Maas R, Sydow K, Meinertz T, Böger RH, Kähler J. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events. Eur Heart J. 2005;26:1846-1851.
11. Maas R, Dentz L, Schwedhelm E, Thoms W, Kuss O, Hiltmeyer N, Haddad M, Klöss T, Standl T, Böger RH. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylar-ginine predict adverse events in patients undergoing noncardiac surgery. Crit Care Med. 2007;35:1876-1881.
12. Zoccali C, Bode-Böger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frölich J, Böger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001;358:2113-2117.
13. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-a meta-analysis. Nephrol Dial Transplant. 2006;21:2446-2451.
14. Schepers E, Glorieux G, Dhondt A, Leybaert L, Vanholder R. Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium infux in monocytes. Nephrol Dial Transplant. 2009;24:1429-1435.
15. Reimann M, Schutte AE, Malan NT, Schwarz PE, Benndorf RA, Schulze F, Böger RH. Asymmetric dimethylarginine is associated with parameters of glucose metabolism in Caucasian but not in African women from South Africa. Exp Clin Endocrinol Diabetes. 2007;115:600-605.
16. Schutte AE, Schutte R, Huisman HW, van Rooyen JM, Fourie CM, Malan L, Malan NT, Schwedhelm E, Strimbeanu S, Anderssohn M, Böger RH. Dimethylarginines: their vascular and metabolic roles in Africans and Caucasians. Eur J Endocrinol. 2010;162:525-533.